Overview
This webinar provides the key updates in terms of managing early COVID with a focus on the role of inhaled steroids like budesonide and the recently introduced Molnupiravir.
Faculty
Dr Raja Dhar
MBBS (Cal), MD (Respiratory Medicine), MRCP (UK) MSc (Evidence Based Medicine, UK) CCT (Respiratory and General Medicine UK), FCCP (USA), Diploma in Palliative Care (Newcastle University) Certificate in Education (Deeside University)
Director & HoD Pulmonology, Fortis Hospital. Director, Research & Education, National Allergy Asthma Bronchitis Institute, Kolkata, India
Dr. Sundeep Salvi
MD, DTCD, DNB, PhD(UK), FCCP (USA), FICS, Hon FRCP (London), Chairman and Director Chest Research and Training Private Limited, Pune, Distinguished Professor of Research Symbiosis International University, Pune President, Indian Chest Society, 2023-2024, Member, Board of Directors, GOLD, Member, Scientific Committee, GINA, Chair, Chronic Respiratory Diseases Section, Global Burden of Disease, India, Member, Steering Committee on Air Pollution and Health, Ministry of Health and Family Welfare, Government of India.Chairman and Director Chest Research and Training Private Limited, Pune Member, Board of Directors, GOLD Member, Governing Council - Indian Chest Society, International Advisory Board Member, Lancet Respiratory Medicine Chair, Chronic Respiratory Diseases Section, GBD, India
Dr. Tanu Singhal
MD (Ped), AIIMS, New Delhi, MSc Tropical Medicine and International Health, London School of Hygiene and Tropical Medicine, LondonConsultant - Pediatrics and Infectious Diseases, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, IndiaResources
External Resources
Management of Early COVID – 2022 Update
Also Read
Our Research
